SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Summer Interns

IP-Watch interns talk about their Geneva experience in summer 2013. 2:42.

Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Quantitative Analysis Of Contributions To NETMundial Meeting

A quantitative analysis of the 187 submissions to the April NETmundial conference on the future of internet governance shows broad support for improving security, ensuring respect for privacy, ensuring freedom of expression, and globalizing the IANA function, analyst Richard Hill writes.


Latest Comments
  • Why should anyone care what James Anaya thinks? In... »
  • If this goes ahead, as the EU will "speak" for all... »

  • For IPW Subscribers

    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >


    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >

    WHO

    11/04/2014: Geneva Health Forum Meets To Discuss Solutions To Common Problems
    09/04/2014: WHO Guidelines May Help With Price Reductions For Hepatitis C Drugs
    07/04/2014: Global Fund And Tiered Medicines Pricing Under Debate
    04/04/2014: MPP Drug Licensing Deal Brings Hope For Greater Access To HIV Treatments
    04/04/2014: UNITAID Publishes Full Report On Health Implications Of TPP
    28/03/2014: Alternative Therapies, Incentive Models Eyed For Antibiotic Resistance
    27/03/2014: WHO Members Discuss Engagement With Non-State Actors This Week
    24/03/2014: Analysis Shows Mixed Results On Big Pharma R&D Efforts For TB
    18/03/2014: Interview With Hans Hogerzeil: Recognising Good Practices Of Pharma
    12/03/2014: Book Challenges ‘Neoliberal’ Approach In Global Public Health Policy
    07/03/2014: WHO Draft Guidelines On Sugars Intake
    03/03/2014: WHO Bulletin Article On Local Pharmaceutical Manufacturing In Africa
    26/02/2014: UNITAID Assesses Potential Implications Of The Trans-Pacific Partnership Agreement
    20/02/2014: Interview With Nazeem Mohamed, CEO Of Kampala Pharmaceutical Industries
    12/02/2014: WHO, IFRC Tap Swiss Federal Funds For New Buildings
    11/02/2014: DNDi Director: ‘Reality Check’ Needed For Neglected Diseases
    31/01/2014: MSF: AstraZeneca Pullout Of Neglected Disease R&D Proof System Broken
    25/01/2014: WHO Sets Path For Model R&D Projects For Developing Countries
    25/01/2014: WHO Board Adopts Resolution On Medicines Access After TRIPS Flexibilities Debate
    24/01/2014: WHO Board Addresses Substandard Medicines, Flu Pandemics, Regulatory Systems
    24/01/2014: WHO Chief: No Government Should Be Intimidated For Doing “Right Thing” In Public Health
    24/01/2014: WHO Board Tackles Reform, Engagement With Non-State Actors
    23/01/2014: Global Health 2035 Report: Flawed Projections
    22/01/2014: New Health Collaboration Touts Ethics, Aims To Put Patients First
    22/01/2014: Concerns Erupt Over Leaked Pharma Lobbying Plan Against IP Policy In South Africa
    21/01/2014: Vaccines In Middle-Income Countries, Noncommunicable Diseases Discussed At WHO
    20/01/2014: WHO Executive Board Opens With Overcrowded Agenda; Chan Calls For Focus
    18/01/2014: WHO Board To Discuss Relationship With Industry, Organisations
    16/01/2014: Successful WHO Drug Prequalification Programme Deemed At Risk
    15/01/2014: WHO Initiative On Poor Quality Medicines Heads To Board Next Week
    17/12/2013: Swiss Group Finds Patent-Related Ethical Violations By Pharma Overseas
    12/12/2013: Medicines Patent Pool Strikes Deal With Bristol-Myers Squibb
    10/12/2013: Concerns Raised To Global Fund Over Panel On Tiered Medicines Pricing
    10/12/2013: IPRs An Issue In Latest HIV Treatment Monitoring Test, Group Says
    09/12/2013: WIPO, OECD, Lessig Hail CC 3.0 Intergovernmental Licence
    06/12/2013: Experts At WHO Select Eight Projects To Boost Medical R&D For Developing Countries
    26/11/2013: Medical R&D Projects Proposed By WHO Regions Show Diversity
    26/11/2013: International Organisations, Industry, Launch Campaign Against Fake Medicines
    22/11/2013: Authors Look At Positive Impact Of Patents On Public Domain
    15/11/2013: Health Diplomacy Spreading, Competent Health Diplomats Needed, Geneva Speakers Say
    06/11/2013: WHO Experts To Narrow Health R&D Projects For Developing Countries At December Meeting
    23/10/2013: Inside Views: WHO Performance Undermined By Inadequate EU Collaboration
    15/10/2013: GAVI: Reducing Prices To Immunise 250 Million Children By 2015
    11/10/2013: WHO Fine-Tuning Pandemic Flu Preparedness Strategy, Use Of Industry Contributions
    07/10/2013: At WTO, Online Pharmacy Watchdog, Tobacco Industry Explain Anti-Counterfeiting Efforts
    02/10/2013: WHO Group To Discuss Plan For Industry Use Of Pandemic Flu Viruses
    10/09/2013: WHO Now Charging Fees For Drug Prequalification, Raising Access Fears
    19/08/2013: WHO Report Calls For Research To Achieve Universal Health Coverage
    05/08/2013: Medicines Patent Pool, Roche Strike HIV-Related Medicine Pricing Agreement
    22/07/2013: WHO Members Meet This Week On Poor Quality Medicines
    Your IP address is 54.205.236.46